Halifax-based DMF Medical has received a Class II medical device license from Health Canada to sell its memsorb carbon dioxide filtration device.
Memsorb is a next generation CO2 removal system for general anesthesia. The product is designed to improve the process of removing carbon dioxide from the system that puts patients to sleep during operations by using membrane technology rather than a chemical reaction.
“We are thrilled to have been able to develop this first-of-its-kind technology in Nova Scotia, and are eager to share it with our colleagues across Canada and around the world,”